Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IMNN | US
0.01
0.69%
Healthcare
Biotechnology
30/06/2024
18/10/2024
0.99
0.97
1.00
0.97
Imunon Inc. a clinical stage biotechnology company engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The Company's lead clinical programs comprise IMNN-001 a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development; and ThermoDox for the treatment of hepatocellular carcinoma. It also has two platform technologies such as TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies; and PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The company was formerly known as Celsion Corporation and changed its name to Imunon Inc. in September 2022. Imunon Inc. was founded in 1982 and is based in Lawrenceville New Jersey.
View LessLow Debt to Asset (< 0.2)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
54.8%1 month
50.4%3 months
385.8%6 months
279.6%-
-
3.79
0.37
0.14
0.91
4.00
-
-19.62M
14.19M
14.19M
-
-
-
-
-143.19
1.64
3.01
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.13
Range1M
0.26
Range3M
2.72
Rel. volume
0.27
Price X volume
58.18K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Evaxion Biotech A/S | EVAX | Biotechnology | 2.64 | 15.58M | -2.58% | n/a | 837.11% |
Indaptus Therapeutics Inc. Common Stock | INDP | Biotechnology | 1.5097 | 15.39M | -2.60% | n/a | 2.12% |
ImmunoPrecise Antibodies Ltd | IPA | Biotechnology | 0.54 | 15.13M | 0.19% | n/a | 49.00% |
Cara Therapeutics Inc | CARA | Biotechnology | 0.2651 | 14.97M | -0.64% | n/a | 406.66% |
Apollomics Inc. Class A Ordinary Shares | APLM | Biotechnology | 0.1281 | 14.09M | 3.98% | n/a | 21.43% |
Aytu BioScience Inc | AYTU | Biotechnology | 2.29 | 14.08M | 0.00% | n/a | 54.59% |
Cingulate Inc. Common Stock | CING | Biotechnology | 4.59 | 13.97M | 2.23% | n/a | 10.72% |
Cyclacel Pharmaceuticals Inc | CYCCP | Biotechnology | 7.3 | 13.88M | n/a | 0.50% | |
Tenax Therapeutics Inc | TENX | Biotechnology | 3.95 | 13.77M | 1.28% | n/a | 3.14% |
NRXP | NRXP | Biotechnology | 1.25 | 13.44M | -1.19% | n/a | -46.73% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.538 | 7.80M | -6.65% | 0.03 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2201 | 3.95M | 4.26% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.76M | 1.92% | n/a | 17.32% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 897.66K | -12.28% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.38 | 0 | 0.37% | 22.53 | 56.33% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.92 | 0 | -8.84% | n/a | 0.00% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4801 | 0 | -10.26% | n/a | 19.98% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.045 | 0 | -2.34% | n/a | 268.43% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.82 | 0 | 1.93% | 9.09 | 39.79% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.91 | 0.53 | Expensive |
Ent. to Revenue | 4.00 | 3,967.00 | Cheaper |
PE Ratio | - | 41.03 | - |
Price to Book | 3.79 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 385.76 | 72.80 | Riskier |
Debt to Equity | 0.37 | -1.23 | Expensive |
Debt to Assets | 0.14 | 0.25 | Cheaper |
Market Cap | 14.19M | 3.66B | Emerging |